KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) EBT Margin (2016 - 2025)

Historic EBT Margin for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 19.17%.

  • Abbott Laboratories' EBT Margin rose 9300.0% to 19.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.56%, marking a year-over-year increase of 21200.0%. This contributed to the annual value of 16.72% for FY2024, which is 1000.0% up from last year.
  • As of Q3 2025, Abbott Laboratories' EBT Margin stood at 19.17%, which was up 9300.0% from 19.3% recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' EBT Margin peaked at 24.18% during Q1 2022, and registered a low of 13.08% during Q4 2022.
  • Its 5-year average for EBT Margin is 17.87%, with a median of 17.53% in 2023.
  • As far as peak fluctuations go, Abbott Laboratories' EBT Margin surged by 113500bps in 2021, and later crashed by -81500bps in 2023.
  • Abbott Laboratories' EBT Margin (Quarter) stood at 20.29% in 2021, then tumbled by -36bps to 13.08% in 2022, then surged by 34bps to 17.53% in 2023, then grew by 6bps to 18.5% in 2024, then grew by 4bps to 19.17% in 2025.
  • Its last three reported values are 19.17% in Q3 2025, 19.3% for Q2 2025, and 17.17% during Q1 2025.